Skip to main content

Articles

Page 2 of 19

  1. Building capacity for evidence-based treatment and support for people with substance use disorders (SUD) is an urgent priority in the context of the toxic drug poisoning crisis. We implemented the first substa...

    Authors: Samantha Robinson, Isabella Brohman, Jenna van Draanen, Rivka Kushner, Nadia Fairbairn and Stephanie Glegg
    Citation: Addiction Science & Clinical Practice 2024 19:93
    Content type: Research Published on:

  2. Hospitalizations involving opioid use disorder (OUD) are increasing. Addiction consultation services (ACS) initiate medications for opioid use disorder (MOUD) in hospital settings and arrange post-hospital fol...

    Authors: Gavin Bart, Kelly S. Barth, Paulette Baukol, Eva Enns, Udi E. Ghitza, Jacklyn Harris, Eve Jelstrom, Jane M. Liebschutz, Kara M. Magane, Delia Voronca, Zoe M. Weinstein and P. Todd Korthuis
    Citation: Addiction Science & Clinical Practice 2024 19:91
    Content type: Study Protocol Published on:

  3. Alcohol use disorder (AUD) poses severe health risks, yet many affected individuals opt out of complete abstinence. Therefore, harm reduction strategies have become more prominent in treatment guidelines for A...

    Authors: Max Schallenberg, Maximilian Pilhatsch, Johannes Petzold, Diana Vogel-Blaschka, Ulrich S. Zimmermann and Maik Spreer
    Citation: Addiction Science & Clinical Practice 2024 19:90
    Content type: Case Report Published on:

  4. The therapeutic alliance is an important predictor of treatment outcomes but people who use alcohol and other drugs report mixed views of treatment providers. We analysed patients’ accounts of inpatient detoxi...

    Authors: Joanne Neale, Beth Cairns, Kevin Gardiner, Wulf Livingston, Trevor McCarthy and Andrew Perkins
    Citation: Addiction Science & Clinical Practice 2024 19:89
    Content type: Research Published on:

  5. Pharmacists play a key role in combating the opioid-related overdose epidemic in the United States (US), but little is known about their experience and willingness to deliver preventive services for opioid use...

    Authors: Li-Tzy Wu, Jacquie King, Kathryn Hefner, Mark Schactman, William John, Nicholas Hagemeier, Abigail G. Matthews, Nathaniel Levitt and Paolo Mannelli
    Citation: Addiction Science & Clinical Practice 2024 19:88
    Content type: Research Published on:

  6. U.S. policy intervention to increase methadone treatment accommodations during COVID did not result in national adoption of the new patient-centered treatment practices. Staff-level interventions may facilitat...

    Authors: Beth E. Meyerson, Linnea B. Linde-Krieger, Gregory A. Carter, Allison J. Huff, Benjamin R. Brady, Richard A. Crosby, Jennifer De La Rosa, Allie Allison, Mohammad Barakat, Michael Pava and Mark Schaefer
    Citation: Addiction Science & Clinical Practice 2024 19:87
    Content type: Research Published on:

  7. There has been a growing interest in the use of psychedelics for therapeutic purposes. However, there is a lack of research on peer recovery coaches' attitudes toward the use of psychedelics for SUD treatment....

    Authors: Veronica Szpak, Amanda Kim, Zachary Sager and Joji Suzuki
    Citation: Addiction Science & Clinical Practice 2024 19:86
    Content type: Brief Report Published on:

  8. Opioid use disorder (OUD) remains a significant public health issue as the number of opioid-related overdose deaths continues to reach new highs each year. Buprenorphine/Naloxone is a medication that has been ...

    Authors: Gary J. Young, Leonard D. Young and Md. Noor-E-Alam
    Citation: Addiction Science & Clinical Practice 2024 19:85
    Content type: Research Published on:

  9. Rates of cocaine use disorder (CUD) among men who have sex with men (MSM) are high and rising. Among MSM, cocaine use is associated with negative socioeconomic, medical, and psychological outcomes. There are n...

    Authors: Elaine Hsiang, Kishan Patel, Erin C. Wilson, Alexandrea Dunham, Janet Ikeda, Tim Matheson and Glenn-Milo Santos
    Citation: Addiction Science & Clinical Practice 2024 19:84
    Content type: Research Published on:

  10. Adolescents increasingly view cannabis as a substance with limited harm. Their propensity to engage in risky driving, combined with their relative driving inexperience, places adolescents at heightened risk fo...

    Authors: Katherine Nameth, Elizabeth Ueland, Elizabeth J. D’Amico and Karen Chan Osilla
    Citation: Addiction Science & Clinical Practice 2024 19:83
    Content type: Research Published on:

  11. As the opioid epidemic continues to have a major negative impact across the US, community pharmacies have come under scrutiny from legal systems attempting to hold them accountable for their role in over dispe...

    Authors: Gerald T. Cochran, Jennifer L. Brown, Ziji Yu, Adam J. Gordon, Stacey Frede, Clinton Hardy, Melissa Castora-Binkley, Felicity Homsted, Lisa A. Marsch, August F. Holtyn and T. John Winhusen
    Citation: Addiction Science & Clinical Practice 2024 19:82
    Content type: Study Protocol Published on:

  12. Pre-exposure prophylaxis (PrEP) holds promise for decreasing new HIV infections among people who inject drugs (PWID), yet daily oral PrEP use is low, and PrEP modality and delivery strategy preferences in this...

    Authors: William H. Eger, Angela R. Bazzi, Chad J. Valasek, Carlos F. Vera, Alicia Harvey-Vera, Steffanie A. Strathdee and Heather A. Pines
    Citation: Addiction Science & Clinical Practice 2024 19:81
    Content type: Research Published on:

  13. Different countries, including Iran, have implemented various policies to address substance use disorder. This study aims to describe the policies related to substance use disorder treatment and identify chall...

    Authors: Saeid Mirzaei, Vahid Yazdi-Feyzabadi, Mohammad Hossein Mehrolhassani, Nouzar Nakhaee and Nadia Oroomiei
    Citation: Addiction Science & Clinical Practice 2024 19:80
    Content type: Research Published on:

  14. In the United States, most (~ 70%) annual newly diagnosed HIV infections are among substance-using sexual minority men (SMM) and gender minority transgender women (trans women). Trans women and SMM are more li...

    Authors: Cathy J. Reback, Raphael J. Landovitz, David Benkeser, Ali Jalali, Steven Shoptaw, Michael J. Li, Raymond P. Mata, Danielle Ryan, Philip J. Jeng and Sean M. Murphy
    Citation: Addiction Science & Clinical Practice 2024 19:79
    Content type: Study Protocol Published on:

  15. There is a rising effort for hospital emergency departments (EDs) to offer and expand substance use disorder (SUD) services. This state-wide evaluation studies SUD services offered along the continuum of imple...

    Authors: Olivia K. Sugarman, Samantha J. Harris, Lauren Byrne, Vivian Flanagan, Sabrina Gattine, Isha Desai, Omeid Heidari, Jason B. Gibbons, Sara Whaley, David Lucas, Tracy Pugh, Allison McBride and Brendan Saloner
    Citation: Addiction Science & Clinical Practice 2024 19:78
    Content type: Research Published on:

  16. Addiction medicine providers have a key role in HIV prevention amidst rising HIV incidence in persons who inject drugs (PWID). Pre-exposure prophylaxis (PrEP) and post-exposure prophylaxis (PEP) are vastly und...

    Authors: Hallie Rozansky, Paul J. Christine, Morgan Younkin, Jason M. Fox, Zoe M. Weinstein, Sebastian Suarez, Jessica Stewart, Natalija Farrell and Jessica L. Taylor
    Citation: Addiction Science & Clinical Practice 2024 19:77
    Content type: Research Published on:

  17. Morbidity and mortality related to substance use have risen to catastrophic levels in North America, and treatment services are often difficult to access. In response, the province of British Columbia (BC), Ca...

    Authors: Anjali Sergeant, Amanda Giesler, Nirupa Goel and Paxton Bach
    Citation: Addiction Science & Clinical Practice 2024 19:76
    Content type: Research Published on:

  18. It is well established that an adolescent’s neighborhood is associated with their likelihood of developing a substance use disorder. The availability of drugs, lack of access to resources, and exposure to viol...

    Authors: Zabin Patel-Syed, Sarah A. Helseth, Robert Rosales, Tim Janssen, Kelli Scott and Sara J. Becker
    Citation: Addiction Science & Clinical Practice 2024 19:75
    Content type: Study Protocol Published on:

  19. In the context of the opioid overdose crisis, understanding the barriers to seeking, attaining and remaining in treatment for patients with opioid use disorder (OUD) is a public health issue. To date, very few...

    Authors: Mélanie Pinhal, Benoit Schreck, Juliette Leboucher, Caroline Victorri-Vigneau, Edouard-Jules Laforgue and Marie Grall-Bronnec
    Citation: Addiction Science & Clinical Practice 2024 19:74
    Content type: Brief Report Published on:

  20. Overdose is a leading cause of maternal mortality; in response, maternal mortality review committees have recommended expanding substance use disorder (SUD) screening, improving collaboration between obstetric...

    Authors: Jessica A. Ratner, Jennifer H. Kirschner, Brittney Spencer and Mishka Terplan
    Citation: Addiction Science & Clinical Practice 2024 19:73
    Content type: Research Published on:

  21. Attrition continues to be a major hurdle for addiction treatment. Through the prism of the attachment theory, this phenomenon can be understood as a manifestation of the patient’s insecure attachment style, ne...

    Authors: Antoine Stocker, Nicolas Navarro, Laurent Schmitt, Marc Delagnes, Aurélie Doualle, Valérie Mallard, Flora Entajan, Karine Guivarc’h, Patricia Masse, Lilian Chaigneau, Baptiste Bonneau, Maryse Lapeyre-Mestre, Christophe Arbus, Antoine Yrondi and Juliette Salles
    Citation: Addiction Science & Clinical Practice 2024 19:72
    Content type: Research Published on:

  22. A minority of people who need alcohol treatment receive it. Unhealthy alcohol use is common among people with HIV (PWH) and can lead to negative health outcomes. The aims of this multi-methods study are to (1)...

    Authors: Christina E. Parisi, Nanyangwe D. Siuluta, Shantrel S. Canidate, Robert L. Cook, Yan Wang, Maya Widmeyer, Charurut Somboonwit, Jessy G. Dévieux and Natalie Chichetto
    Citation: Addiction Science & Clinical Practice 2024 19:71
    Content type: Research Published on:

  23. Scholarship on how fentanyl affects the complexities of correctional settings is limited in Canada, as scholars have focused on the prevalence of opioid use and overdose in prisons, as well as community treatm...

    Authors: Rosemary Ricciardelli, Matthew S. Johnston and Gillian Foley
    Citation: Addiction Science & Clinical Practice 2024 19:70
    Content type: Research Published on:

  25. Incarceration provides an opportunity for health interventions, including opioid use disorder (OUD) treatment and prevention of opioid-related overdoses post-release. All FDA-approved forms of medication for O...

    Authors: Thomas J. Stopka, Rebecca Rottapel, Peter D. Friedmann, Ekaterina Pivovarova and Elizabeth A. Evans
    Citation: Addiction Science & Clinical Practice 2024 19:68
    Content type: Research Published on:

  26. Adolescents with chronic medical conditions (CMC) use alcohol and marijuana at levels equal to or even greater than their peers without CMC and are more likely to initiate substance use at 14 years or younger....

    Authors: Faith Summersett Williams, Robert Garofalo, Niranjan S. Karnik, Geri Donenberg, Hayley Centola, Sara Becker, Sarah Welch and Lisa Kuhns
    Citation: Addiction Science & Clinical Practice 2024 19:67
    Content type: Study Protocol Published on:

  27. Patients with chronic pain on opioids frequently experience loneliness, which is associated with poorer health outcomes and higher risk for opioid misuse and opioid use disorder. Given that almost half of opio...

    Authors: Sebastian T. Tong, Kris Pui Kwan Ma, Ajla Pleho, Brennan Keiser, Chialing Hsu, Dawn M. Ehde, Mary C. Curran, Judith I. Tsui, Patrick J. Raue and Kari A. Stephens
    Citation: Addiction Science & Clinical Practice 2024 19:66
    Content type: Study Protocol Published on:

  28. Hazardous alcohol use and alcohol use disorder (AUD) are highly prevalent among clients in mental health services, yet significant gaps remain in the adequate assessment of alcohol use and provision of appropr...

    Authors: Nathalie Kools, Andrea D. Rozema, Fieke A. E. van den Bulck, Rob H. L. M. Bovens, Jolanda J. P. Mathijssen and Dike van de Mheen
    Citation: Addiction Science & Clinical Practice 2024 19:65
    Content type: Research Published on:

  29. Unhealthy alcohol use represents a significant risk for morbidity and mortality among people living with HIV (PLWH), in part through its impact on HIV management. Chronic pain, a common comorbidity, exacerbate...

    Authors: Tibor P Palfai, Lauren B Bernier, Maya PL Kratzer, Kara M Magane, Sarah Fielman, John D Otis, Timothy C Heeren, Michael R Winter and Michael D Stein
    Citation: Addiction Science & Clinical Practice 2024 19:64
    Content type: Study Protocol Published on:

  30. Opioid related overdose morbidity and mortality continue to significantly impact rural communities. Nationwide, emergency departments (EDs) have seen an increase in opioid use disorder (OUD)-related visits com...

    Authors: Natasha Seliski, Troy Madsen, Savannah Eley, Jennifer Colosimo, Travis Engar, Adam Gordon, Christinna Barnett, Grace Humiston, Taylor Morsillo, Laura Stolebarger, Marcela C Smid and Gerald Cochran
    Citation: Addiction Science & Clinical Practice 2024 19:63
    Content type: Study Protocol Published on:

  31. Unhealthy alcohol use is a common public health problem in HIV care settings in Africa and it affects the HIV continuum of care. In Uganda and other low-income countries, HIV care providers are a key resource ...

    Authors: Raymond Felix Odokonyero, Noeline Nakasujja, Andrew Turiho, Naomi Sanyu, Winnie R. Muyindike, Denis Nansera, Fred Semitala, Moses R. Kamya, Anne R. Katahoire, Judith A. Hahn, Carol C. Camlin and Wilson W. Muhwezi
    Citation: Addiction Science & Clinical Practice 2024 19:62
    Content type: Research Published on:

  32. Diagnosis of alcohol use disorder (AUD) in primary care is critical for increasing access to alcohol treatment. However, AUD is underdiagnosed and may be inequitably diagnosed due to societal structures that d...

    Authors: Robert L. Ellis, Kevin A. Hallgren, Emily C. Williams, Joseph E. Glass, Isaac C. Rhew, Malia Oliver and Katharine A. Bradley
    Citation: Addiction Science & Clinical Practice 2024 19:61
    Content type: Research Published on:

  33. Many people with opioid use disorder who stand to benefit from buprenorphine treatment are unwilling to initiate it due to experience with or fear of both spontaneous and buprenorphine-precipitated opioid with...

    Authors: Lucinda A. Grande, Tom Hutch, Keira Jack, Wendy Mironov, Jessica Iwuoha, Martin Muy-Rivera, Jacob Grillo, Stephen A. Martin and Andrew Herring
    Citation: Addiction Science & Clinical Practice 2024 19:60
    Content type: Research Published on:

  35. Although clinical substance use disorder (SUD) care is multidisciplinary there are few opportunities to collaborate for quality improvement or systems change. In Oregon, the Project ECHO (Extension for Communi...

    Authors: NithyaPriya Ramalingam, Eowyn Rieke, Maggie McLain McDonnell, Emily Myers and Dan Hoover
    Citation: Addiction Science & Clinical Practice 2024 19:58
    Content type: Research Published on:

  36. Substance use disorders (SUDs) have been consistently shown to exhibit moderate intergenerational continuity (1–3). While much research has examined genetic and social influences on addiction, less attention h...

    Authors: Amanda Keller, Emily A. Bosk, Alicia Mendez, Brett Greenfield, Carolynn Flynn, Gina Everett (DelJones), Fabrys Julien and MacKenzie Michael
    Citation: Addiction Science & Clinical Practice 2024 19:57
    Content type: Research Published on:

  37. Despite continuing advancements in treatments for opioid use disorder (OUD), continued high rates of relapse indicate the need for more effective approaches, including novel pharmacological interventions. Gluc...

    Authors: Christopher S. Freet, Brianna Evans, Timothy R. Brick, Erin Deneke, Emily J. Wasserman, Sarah M. Ballard, Dean M. Stankoski, Lan Kong, Nazia Raja-Khan, Jennifer E. Nyland, Amy C. Arnold, Venkatesh Basappa Krishnamurthy, Julio Fernandez-Mendoza, H. Harrington Cleveland, Adam D. Scioli, Amanda Molchanow…
    Citation: Addiction Science & Clinical Practice 2024 19:56
    Content type: Study Protocol Published on:

  38. In the U.S. there are significant racial and gender disparities in the uptake of pre-exposure prophylaxis (PrEP). Black Americans represented 14% of PrEP users in 2022, but accounted for 42% of new HIV diagnos...

    Authors: Dawn Goddard-Eckrich, Tara McCrimmon, Keosha Bond, Mingway Chang, Timothy Hunt, Jennifer Hall, Mary Russo, Vineha Ramesh, Karen A. Johnson, Dget L. Downey, Elwin Wu, Nabila El-Bassel and Louisa Gilbert
    Citation: Addiction Science & Clinical Practice 2024 19:55
    Content type: Research Published on:

  40. Overdose deaths continue to rise within the United States, despite effective treatments such as buprenorphine and methadone for opioid use disorder (OUD). Mobile medical units with the ability to dispense bupr...

    Authors: Sarah E. Messmer, Abigail T. Elmes, Alexander F. Infante, Anna Patterson, Mackenzie Smith, Albert Leon Murphy, Antonio D. Jimenez, Stockton Mayer, Dennis P. Watson, Kevin Whitfield, Steven J. Fisher and Jennie B. Jarrett
    Citation: Addiction Science & Clinical Practice 2024 19:53
    Content type: Research Published on:

  41. Cigarette smoking remains a leading cause of preventable illness and death, underscoring the need for effective evidence-based smoking cessation interventions. Nuumi, a novel smoking cessation program integrat...

    Authors: Helen Schiek, Tobias Esch, Maren M. Michaelsen and Cosima Hoetger
    Citation: Addiction Science & Clinical Practice 2024 19:52
    Content type: Study Protocol Published on:

  42. Clinic-based interventions are needed to promote successful direct acting antiviral (DAA) treatment for chronic hepatitis C virus (HCV) infection in patients with substance use disorders (SUDs) among rural Vet...

    Authors: Mary Jane Burton, Andrew C. Voluse and Amee B. Patel
    Citation: Addiction Science & Clinical Practice 2024 19:51
    Content type: Research Published on:

  43. Buprenorphine is an effective and safe treatment for opioid use disorder, but the requirement for moderate opioid withdrawal symptoms to emerge prior to initiation is a significant treatment barrier.

    Authors: Pouya Azar, Hannah Schneiderman, Henry Barron, James S. H. Wong, Maximilian Meyer, Dayyon Newman-Azar, Matin Narimani, Martha J. Ignaszewski, Nickie Mathew, Rodney Mullen, Reinhard M. Krausz and Anil R. Maharaj
    Citation: Addiction Science & Clinical Practice 2024 19:50
    Content type: Case Study Published on:

  44. The 15-method is a targeted screening and treatment approach for alcohol problems in primary care. The 15-method used in primary care has proven as effective as specialized treatment for mild to moderate alcoh...

    Authors: Peter Næsborg Schøler, Kristina Hasselbalch Volke, Sven Andréasson, Sanne Rasmussen, Jens Søndergaard and Anette Søgaard Nielsen
    Citation: Addiction Science & Clinical Practice 2024 19:49
    Content type: Study Protocol Published on:

  45. Regulations put in place to protect the privacy of individuals receiving substance use disorder (SUD) treatment have resulted in an unintended consequence of siloed SUD treatment and referral information outsi...

    Authors: Alexandra R. Tillman, Emily Bacon, Brooke Bender, Dean McEwen, Joshua Blum, Matthew Hoag, Kenneth A. Scott, Rachel Everhart, Rebecca Hanratty, Laura J. Podewils, Carolina Close, John Mills and Arthur J. Davidson
    Citation: Addiction Science & Clinical Practice 2024 19:48
    Content type: Research Published on:

  46. Women who engage in sex work and use drugs (WSWUD) experience disproportionate HIV risks. Substance use treatment bridge clinics offer an opportunity to increase HIV pre-exposure prophylaxis (PrEP) delivery to...

    Authors: Miriam TH Harris, Emma Weinberger, Christine O’Brien, Mary Althoff, Samantha Paltrow-Krulwich, Jessica L. Taylor, Abigail Judge, Jeffrey H. Samet, Alexander Y. Walley and Christine M. Gunn
    Citation: Addiction Science & Clinical Practice 2024 19:47
    Content type: Research Published on:

  47. Implementation of pre-exposure prophylaxis (PrEP) to prevent HIV transmission is suboptimal in the United States, particularly among people who use drugs (PWUD). PrEP research among PWUD is scarce, and the fac...

    Authors: James L. Merle, Juan P. Zapata, Artur Quieroz, Alithia Zamantakis, Olutobi Sanuade, Brian Mustanski and Justin D. Smith
    Citation: Addiction Science & Clinical Practice 2024 19:46
    Content type: Review Published on:

  48. Supervised injectable opioid treatment (SIOT) is a promising alternative for people living with opioid use disorder (OUD) who have not sufficiently benefitted from oral opioid substitution treatment. Yet, SIOT...

    Authors: Zoe Friedmann, Hans-Tilmann Kinkel, Claudia Kühner, Andreas Zsolnai, Annette Binder and Inge Mick
    Citation: Addiction Science & Clinical Practice 2024 19:45
    Content type: Research Published on:

  49. Norway has a growing proportion of ageing opioid agonist treatment (OAT) patients, with 42% of the 8300 Norwegian OAT patients aged over 50 in 2022. This study aims to explore practitioners’ views and experien...

    Authors: John Todd-Kvam and Thomas Clausen
    Citation: Addiction Science & Clinical Practice 2024 19:44
    Content type: Research Published on:

  50. To assess the extent of Coronavirus-related disruption to health and social care treatment and social interactions among people with lived or living experience of substance use in Scotland, and explore potenti...

    Authors: Mark McCann, Federica Bianchi, Srebrenka Letina, Samantha Stewart, Katy McLeod and Mark Tranmer
    Citation: Addiction Science & Clinical Practice 2024 19:42
    Content type: Research Published on:
Submit manuscript
  • New Content Item

Follow

Affiliated with

Annual Journal Metrics

  • Citation Impact 2023
    Journal Impact Factor: 3.7
    5-year Journal Impact Factor: 4.2
    Source Normalized Impact per Paper (SNIP): 1.062
    SCImago Journal Rank (SJR): 1.307

    Speed 2024
    Submission to first editorial decision (median days): 17
    Submission to acceptance (median days): 250

    Usage 2024
    Downloads: 627,221
    Altmetric mentions: 247

Archival content

Addiction Science & Clinical Practice was formerly published by NIDA and previous issues of the journal can be viewed here.

Addiction Science & Clinical Practice

ISSN: 1940-0640